Windlas Biotech makes underwhelming market debut, lists at 5% discount on issue price
Leading pharmaceutical development services company, Windlas Biotech, has made a tepid market debut on the stock market after its initial public offering (IPO). On the Bombay Stock Exchange (BSE), the stock got listed at Rs 439, down nearly 5 per cent from the issue price of Rs 460. It fell to over 8 per cent at 11:30…
